Issued Patents All Time
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10034936 | Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein | Jack T. Stapleton, Donna Klinzman, James McLinden | 2018-07-31 |
| 9611301 | GB virus C (hepatitis G virus) E2 glycoprotein as an immunomodulatory agent | Jack T. Stapleton, Nirjal Bhattarai, James McLinden | 2017-04-04 |
| 8858946 | Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies | Jack T. Stapleton, Donna Klinzman, James McLinden | 2014-10-14 |
| 8268778 | Flavivirus NS5A proteins for the treatment of HIV | James McLinden, Jack T. Stapleton | 2012-09-18 |
| 7951531 | Flavivirus NS5A proteins for the treatment of HIV | Jack T. Stapleton, Qing Chang, James McLinden | 2011-05-31 |
| 7291723 | GB virus C and methods of treating viral infections | Jack T. Stapleton, Sarah Danger George | 2007-11-06 |
| 6870043 | Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4 positive T cells | Sabina Wünschmann, Warren Schmidt, Jack T. Stapleton | 2005-03-22 |